FR2889066B1 - Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede - Google Patents

Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede

Info

Publication number
FR2889066B1
FR2889066B1 FR0508065A FR0508065A FR2889066B1 FR 2889066 B1 FR2889066 B1 FR 2889066B1 FR 0508065 A FR0508065 A FR 0508065A FR 0508065 A FR0508065 A FR 0508065A FR 2889066 B1 FR2889066 B1 FR 2889066B1
Authority
FR
France
Prior art keywords
electrotransfer
antiserum
genetic immunization
against toxin
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0508065A
Other languages
English (en)
Other versions
FR2889066A1 (fr
Inventor
Daniel Scherman
Pascal Bigey
Capucine Trollet
Michel Robert Popoff
Yannick Pereira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris 5 Rene Descartes
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris 5 Rene Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Paris 5 Rene Descartes filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0508065A priority Critical patent/FR2889066B1/fr
Priority to US11/989,573 priority patent/US20100129371A1/en
Priority to JP2008523373A priority patent/JP2009502880A/ja
Priority to EP06778059A priority patent/EP1906996A2/fr
Priority to PCT/EP2006/064798 priority patent/WO2007012671A2/fr
Priority to CA002617082A priority patent/CA2617082A1/fr
Publication of FR2889066A1 publication Critical patent/FR2889066A1/fr
Application granted granted Critical
Publication of FR2889066B1 publication Critical patent/FR2889066B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0508065A 2005-07-28 2005-07-28 Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede Expired - Fee Related FR2889066B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0508065A FR2889066B1 (fr) 2005-07-28 2005-07-28 Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede
US11/989,573 US20100129371A1 (en) 2005-07-28 2006-07-28 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method
JP2008523373A JP2009502880A (ja) 2005-07-28 2006-07-28 毒素に対する電気移動による遺伝子免疫法および前記方法によって得られる抗血清
EP06778059A EP1906996A2 (fr) 2005-07-28 2006-07-28 Procédé d'immunisation génétique par électrotransfert contre une toxine et antisérum susceptible d'être obtenu par ledit procédé
PCT/EP2006/064798 WO2007012671A2 (fr) 2005-07-28 2006-07-28 Procédé d'immunisation génétique par électrotransfert contre une toxine et antisérum susceptible d'être obtenu par ledit procédé
CA002617082A CA2617082A1 (fr) 2005-07-28 2006-07-28 Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508065A FR2889066B1 (fr) 2005-07-28 2005-07-28 Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede

Publications (2)

Publication Number Publication Date
FR2889066A1 FR2889066A1 (fr) 2007-02-02
FR2889066B1 true FR2889066B1 (fr) 2007-11-09

Family

ID=36101879

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0508065A Expired - Fee Related FR2889066B1 (fr) 2005-07-28 2005-07-28 Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede

Country Status (6)

Country Link
US (1) US20100129371A1 (fr)
EP (1) EP1906996A2 (fr)
JP (1) JP2009502880A (fr)
CA (1) CA2617082A1 (fr)
FR (1) FR2889066B1 (fr)
WO (1) WO2007012671A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928373B1 (fr) * 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
WO2011143557A2 (fr) 2010-05-14 2011-11-17 The Children's Hospital Of Philadelphia Ttc humanisé et procédés d'utilisation associés
EP2968509A4 (fr) * 2013-03-15 2016-03-23 Univ Pennsylvania Vaccin à base de neurotoxine botulinique mono ou multivalente utilisant la chaîne lourde de sérotypes de clostridium botulinum
CN111122455B (zh) * 2019-12-20 2022-10-25 华南协同创新研究院 一种食品真菌毒素结构的稳定性判定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000067700A2 (fr) * 1999-05-12 2000-11-16 United States Army Medical Research & Materiel Cmd Vaccin de recombinaison contre la neurotoxine botulique
JPH10136990A (ja) * 1996-09-18 1998-05-26 Boehringer Mannheim Gmbh Ｇ型肝炎ウイルスに対する抗体、ｈｇｖの診断検出のた めのおよび治療薬としてのその使用
JP2002507985A (ja) * 1997-06-30 2002-03-12 ローヌ−プーラン・ロレ・エス・アー 横紋筋に核酸を導入する改良法およびその組合せ
WO2003012117A1 (fr) * 2001-07-28 2003-02-13 The Secretary Of State For Defence Vaccin a adn
WO2004064750A2 (fr) * 2003-01-22 2004-08-05 Duke University Constructions ameliorees permettant d'exprimer des polypeptides lysosomiaux

Also Published As

Publication number Publication date
US20100129371A1 (en) 2010-05-27
CA2617082A1 (fr) 2007-02-01
WO2007012671A2 (fr) 2007-02-01
WO2007012671A9 (fr) 2007-03-15
WO2007012671A3 (fr) 2007-04-26
JP2009502880A (ja) 2009-01-29
EP1906996A2 (fr) 2008-04-09
FR2889066A1 (fr) 2007-02-02

Similar Documents

Publication Publication Date Title
NO20076404L (no) Humaniserte anti-CD40 antistoffer og deres anvendelsesmetoder
FR2909286B1 (fr) Methode d'immunisation contre les 4 serotypes de la dengue
UA95478C2 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТ с-Kit
BRPI1006270A2 (pt) ''anticorpo anti a5b1, molécula de ácido nucleio isolado, célula hospedeira, método de produção de um anticorpo anti a5b1, imunoconjugado, composição farmacêutica, método de detecção de proteína a5b1, método de tratamento de um indivíduo e kit de detecção de a5b1
FR2898603B1 (fr) Nouveaux polyurethanes, compositions les comprenant et procede de traitement cosmetique
TN2012000555A1 (en) Antibodies to human gdf8
DK1691196T3 (da) Chip med mikrobrøndsarray og fremgangsmåde til fremstilling heraf
NO20082305L (no) Mikrobiologisk stabilisert ol
NO20083702L (no) Suspensjon for skjæring av silikonblokk og fremgangsmåte for skjæring av silikonblokk med denne
BRPI0914092A2 (pt) método de produção de um anticorpo a partir de células plasmáticas, método de produção de um anticorpo monoclonal a partir de células plasmáticas, método de produção de um anticorpo ou de um fragmento de anticorpo, anticorpo isolado ou fragmento de anticorpo, anticorpo ou fragmento de anticorpo e composição farmacêutica
DK1960434T3 (da) Monoklonale, humane antistoffer mod Fucosyl-GM1 og fremgangsmåder til anvendelse af anti-Fucosyl-GM1
DK2201956T3 (da) Kornformet geleret drikkevare til medicinering og fremgangsmåde til fremstilling af samme
DK1791852T3 (da) C-aryl glucosid -SGLT2-inhibitorer og metode til deres fremstilling
WO2007022529A3 (fr) Méthode pour traiter des maladies inflammatoires
EP2083017A4 (fr) Anticorps présentant une activité adcc accrue et son procédé de production
PL373754A1 (en) Method for manufacture of string shaped mozarella type cheese product and string shaped mozarella type cheese product
FR2897204B1 (fr) Structure de transistor vertical et procede de fabrication
EP2089909A4 (fr) Structure de porte entierement et uniformement siliciuree et son procede de formation
NO20042425D0 (no) Fremgangsmate og anordning for algeproduksjon
WO2012082752A3 (fr) Anticorps anti-ccl25 et anti-ccr9 pour la prévention et le traitement du cancer et de la migration de cellules cancéreuses
FR2889066B1 (fr) Procede d'immunisation genetique par electrotransfert contre une toxine et antiserum susceptible d'etre obtenu par ledit procede
NO20054286L (no) Isolert beholder, fremgangsmate for fremstilling av samme og apparat for fremstilling
DK1518827T3 (da) Krystalliseret IM-12-faststof og fremgangsmåde til fremstilling heraf
EP1859806A4 (fr) Composition pharmaceutique et procede pour traiter le psoriasis, le carcinome spinocellulaire ou la parakeratose en inhibant l expression de l antigene relie au carcinome spinocellulaire
WO2007149560A3 (fr) Fermentation et purification d'une chromoprotéine d'actinomadura et des espèces apparentées

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140331